1. [SYSTEMIC CYTOKINOTHERAPY, USING BETALEUKIN IN A COMPLEX TREATMENT OF AN ACUTE GASTRODUODENAL ULCER BLEEDING].
- Author
-
Gadjiyev JN, Allakhverdiyev VA, Sushkov SV, Gadjiyev NJ, Yagubova VI, and Lavinskaya EV
- Subjects
- Adolescent, Adult, Aged, Antigen-Antibody Complex blood, Antigens, CD immunology, Case-Control Studies, Female, Gastrointestinal Hemorrhage etiology, Gastrointestinal Hemorrhage immunology, Gastrointestinal Hemorrhage surgery, Humans, Immunoglobulin A blood, Immunoglobulin G blood, Immunoglobulin M blood, Immunophenotyping, Lymphocytes drug effects, Lymphocytes immunology, Lymphocytes pathology, Male, Middle Aged, Peptic Ulcer complications, Peptic Ulcer immunology, Peptic Ulcer surgery, Recombinant Proteins therapeutic use, Severity of Illness Index, Stomach Ulcer complications, Stomach Ulcer immunology, Stomach Ulcer surgery, Treatment Outcome, Gastrointestinal Hemorrhage drug therapy, Immunologic Factors therapeutic use, Interleukin-1beta therapeutic use, Peptic Ulcer drug therapy, Stomach Ulcer drug therapy
- Abstract
Results of surgical treatment for an acute ulcer gastroduodenal bleeding in 120 patients, ageing 16-75 yrs old, were analyzed. In 20 of them a gastric ulcer was a cause of bleeding, while in 84--a duodenal ulcer, and in 16--a coexistent gastroduodenal ulcer. The bleeding activity was estimated in accordance to J. Forrest classification. In 57 patients (a comparison group) preoperatively and postoperatively a complex of a standard basal conservative therapy without immunocorrection was conducted, and in 63 (the main group)--a systemic cytokinotherapy (SCKTH), using betaleukin, was applied postoperatively additionally in a complex of therapy. A content of CD3+, CD4+, CD8+, CD19+, IgA, IgM, IgG was estimated in dynamics, as well as circulating immune complexes, phagocytic index, phagocytic number. There was established, that a dysbalance depth in the immune status have had depended upon the blood loss severity. The SCKTH application is pathogenetically substantiated, it promotes the immune status normalization, as well as a more favorable course of postoperative period and the results of treatment improvement.
- Published
- 2016